tiprankstipranks
cbdMD (YCBD)
:YCBD
US Market
Holding YCBD?
Track your performance easily

cbdMD (YCBD) Earnings Dates, Call Summary & Reports

350 Followers

Earnings Data

Report Date
Feb 12, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
Last Year’s EPS
Same Quarter Last Year
Based on 0 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Dec 13, 2018
|
% Change Since: 37.50%
|
Next Earnings Date:Aug 14, 2018
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture. While there were notable improvements in reducing net loss, enhancing customer experience, and operational efficiencies, these were offset by declines in net sales, marketing challenges, and wholesale declines. The company's efforts to innovate and expand in new product lines like the Oasis Social Tonics show promise, but financial performance needs improvement to sustain long-term growth.
Company Guidance
During the Q4 2024 earnings call for cbdMD, the company shared several key financial metrics and strategic updates. The net loss improved by over $19 million for the year, with a fourth-quarter reduction to $152,000 from a prior $15.9 million. The company achieved strong normalized gross margins and nearly eliminated its non-GAAP adjusted EBITDA loss for two consecutive quarters. E-commerce sales, representing 80% of total net sales, reached $3.7 million, though this marked a 19% year-over-year decrease. Overall, fiscal 2024 net sales were $19.5 million, down from $24.1 million in the previous year. The company maintained a gross profit margin of 54% for the fourth quarter, adjusting to 67% when excluding a $588,000 inventory write-off. SG&A expenses dropped significantly, contributing to an operating loss reduction to $300,000, compared to $15.2 million in the prior year. Non-GAAP adjusted EBITDA loss for fiscal 2024 was $1.5 million, a substantial improvement from $5.5 million in fiscal 2023. Additionally, the company's cash balance increased to $2.4 million, with a working capital of negative $1 million, primarily due to accrued preferred dividends. Despite challenges, cbdMD is optimistic about its financial position and growth prospects heading into 2025.
Significant Reduction in Net Loss
The net loss improved by over $19 million for the year, with a reduction to $152,000 in the fourth quarter from $15.9 million in the prior period.
Positive Customer Feedback on New Products
Successfully relaunched the sleep product with an improved formula, and early customer feedback has been overwhelmingly positive. Additionally, the new Oasis Social Tonics have received outstanding early reviews.
Operational Efficiency and Cost Reduction
SG&A expenses were reduced from $24.2 million to $15.3 million for the fiscal year, demonstrating management's focus on cost structure and profitability.
Publication of Canine Study
A study was published showing that cbdMD's core blend improved pain relief and mobility in dogs, reinforcing the company's commitment to science and safety.
---

cbdMD (YCBD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

YCBD Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 14, 20182018 (Q3)
- / 0.03
Dec 13, 20182018 (Q4)
- / -0.11
Feb 15, 20192019 (Q1)
- / -0.06
-0.1662.50% (+0.10)
May 16, 20192019 (Q2)
- / -140.85
0.17-82952.94% (-141.02)
Aug 14, 20192019 (Q3)
- / -53.55
1.35-4066.67% (-54.90)
Dec 18, 20192019 (Q4)
- / -15.75
-4.928-219.60% (-10.82)
Feb 13, 20202020 (Q1)
- / 20.44
-2.7857.11% (+23.14)
May 18, 20202020 (Q2)
- / 17.94
-140.85112.74% (+158.79)
Aug 12, 20202020 (Q3)
- / -8.10
-53.5584.87% (+45.45)
Dec 22, 20202020 (Q4)
- / -17.68
-15.75-12.27% (-1.93)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

YCBD Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Dec 18, 2024$0.40$0.37-7.50%
Aug 14, 2024$0.48$0.49+2.08%
May 15, 2024$0.71$0.710.00%
Feb 13, 2024$0.70$0.64-8.57%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does cbdMD (YCBD) report earnings?
cbdMD (YCBD) is schdueled to report earning on Feb 12, 2025, TBA Not Confirmed.
    What is cbdMD (YCBD) earnings time?
    cbdMD (YCBD) earnings time is at Feb 12, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is YCBD EPS forecast?
          Currently, no data Available
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis